On Tuesday, December 15th, MassCONNECT held its final showcase and holiday party, celebrating the achievements of this year’s MassCONNECT entrepreneurs and mentors.
On this special occasion, MassCONNECT debuted three new videos that capture the impact of the program on mentors and mentees.
MassCONNECT: A Life Sciences Mentoring Program
MassCONNECT Testimonial: Aldatu Biosciences
After the big video reveal, entrepreneurs gave a final pitch to their mentors and life sciences industry stakeholders at Cooley LLP’s Boston office.
Blue Therapeutics, (www.bluetherapeutics.com), founded by Michio Painter, PhD, David Roberson, MBA, PhD Candidate and Ajay Yekkirala, PhD is advancing a patented, novel small molecule that has 50x greater painkilling potency than morphine and is completely non-addictive.
Pretium, founded by Isaac Kohane, MD, PhD and Griffin Weber, MD, PhD is developing a medical informatics-based platform to better match patients with clinical trials, accelerate recruitment, cut overall trial costs and ultimately reduce healthcare costs.
PanTher Therapeutics (www.panthertx.com), founded by Laura Indolfi, PhD, is developing a drug-device combination platform to suppress tumor growth of inoperable solid tumors from pancreatic and other cancers, ultimately reducing overall healthcare costs by increasing the number of curable patients and minimizing repeated procedures.
MassBio’s Chief Business Officer John Hallinan graciously thanked the mentors and mentees for all of their hard work and remarked that the “The future has never looked brighter for MassCONNECT.”
View the Facebook album with pictures from the MassCONNECT final showcase and holiday party and keep an eye out for the new MassCONNECT cycles in 2016!